Indoleamine 2,3-dioxygenase in tumor induced tolerance

被引:17
|
作者
Liu Xiao-qian [1 ]
Wang Xin [1 ]
机构
[1] Shandong Univ, Dept Hematol, Prov Hosp, Jinan 250021, Shandong, Peoples R China
关键词
indoleamine 2,3-dioxygenase; immune tolerance; dendritic cells; regulatory T cells; 1-methyl-tryptophan; REGULATORY T-CELLS; PLASMACYTOID DENDRITIC CELLS; DRAINING LYMPH-NODES; TRYPTOPHAN CATABOLISM; BACTERIAL LIPOPOLYSACCHARIDE; INCREASED POPULATIONS; PERIPHERAL-BLOOD; IDO; INHIBITION; EXPRESSION;
D O I
10.3760/cma.j.issn.0366-6999.2009.24.030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To review the recent studies about the role of indoleamine 2,3-dioxygenase (IDO) in tumor induced tolerance. Data sources Published articles (1978-2009) on IDO and tumor induced tolerance were selected from Medline. Study selection Articles selected were relevant to development of IDO in tumor induced tolerance. Of all originally identified articles, 50 specially addressed the stated purpose. Results Recent work has revealed IDO at high levels in tumors and in tumor-draining lymph nodes and a close relationship between IDO activity and the regulatory T cells. Conclusion Up-regulation of IDO is proven to be a mechanism of acquired tolerance in tumors, in which the closely coupled positive feedback system between IDO and regulatory T cells may be considered to play an important role. Chin Med J 2009,122(24):3072-3077
引用
收藏
页码:3072 / 3077
页数:6
相关论文
共 50 条
  • [41] The role of serine 167 in human indoleamine 2,3-dioxygenase: A comparison with tryptophan 2,3-dioxygenase
    Chauhan, Nishma
    Basran, Jaswir
    Efimov, Igor
    Svistunenko, Dimitri A.
    Seward, Harriet E.
    Moody, Peter C. E.
    Raven, Emma Lloyd
    BIOCHEMISTRY, 2008, 47 (16) : 4761 - 4769
  • [42] Indoleamine 2,3-Dioxygenase 1: A Promising Therapeutic Target in Malignant Tumor
    Song, Xiaotian
    Si, Qianqian
    Qi, Rui
    Liu, Weidan
    Li, Miao
    Guo, Mengyue
    Wei, Lin
    Yao, Zhiyan
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [43] Resveratrol suppresses tumor progression via the regulation of indoleamine 2,3-dioxygenase
    Noh, Kyung Tae
    Chae, Seung Hoon
    Chun, Sung Hak
    Jung, In Duk
    Kang, Hyun Kyu
    Park, Yeong-Min
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 431 (02) : 348 - 353
  • [44] Indoleamine 2,3-dioxygenase in immune suppression and cancer
    Muller, Alexander J.
    Prendergast, George C.
    CURRENT CANCER DRUG TARGETS, 2007, 7 (01) : 31 - 40
  • [45] Substrate Inhibition in Human Indoleamine 2,3-Dioxygenase
    Weber, Benjamin
    Nickel, Elena
    Horn, Michael
    Nienhaus, Karin
    Nienhaus, G. Ulrich
    JOURNAL OF PHYSICAL CHEMISTRY LETTERS, 2014, 5 (04): : 756 - 761
  • [46] Immunotherapeutic Suppression of Indoleamine 2,3-Dioxygenase and Tumor Growth with Ethyl Pyruvate
    Muller, Alexander J.
    DuHadaway, James B.
    Jaller, Daniel
    Curtis, Peter
    Metz, Richard
    Prendergast, George C.
    CANCER RESEARCH, 2010, 70 (05) : 1845 - 1853
  • [47] NADH Oxidase Activity of Indoleamine 2,3-Dioxygenase
    Rosell, Federico I.
    Kuo, Hsin H.
    Mauk, A. Grant
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (33) : 29273 - 29283
  • [48] Role of indoleamine 2,3-dioxygenase in health and disease
    Yeung, Amanda W. S.
    Terentis, Andrew C.
    King, Nicholas J. C.
    Thomas, Shane R.
    CLINICAL SCIENCE, 2015, 129 (07) : 601 - 672
  • [49] GENE STRUCTURE OF HUMAN INDOLEAMINE 2,3-DIOXYGENASE
    KADOYA, A
    TONE, S
    MAEDA, H
    MINATOGAWA, Y
    KIDO, R
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 189 (01) : 530 - 536
  • [50] Indoleamine 2,3-dioxygenase in the pathogenesis of tuberculous pleurisy
    Suzuki, Y.
    Miwa, S.
    Akamatsu, T.
    Suzuki, M.
    Fujie, M.
    Nakamura, Y.
    Inui, N.
    Hayakawa, H.
    Chida, K.
    Suda, T.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2013, 17 (11) : 1501 - 1506